CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,012)	$ (25)	$ (500)
Adjustments to reconcile net loss to net cash provided by operating activities:
Net loss (gain) from securities transactions	595	52	(1,206)
Purchases of securities	(963)	(2,985)	(2,158)
Proceeds from sales of securities	4,537	5,359	4,172
Payments to cover securities sold, not yet purchased	(4,692)	(2,908)	(2,775)
Proceeds from securities sold, not yet purchased	1,358	3,836	4,025
Changes in receivables and payables relating to securities transactions	2,268	(2,390)	(2,035)
Changes in derivative assets and liabilities	1,029	(296)	321
(Gain) loss on disposition of assets, net	(8)	8	(141)
Depreciation and amortization	518	509	517
Loss on deconsolidation of subsidiary	246
Credit loss expense	139
Impairment	7
Deferred taxes	(48)	(148)	(168)
Inventory write-down		84	59
Other, net	(84)	72	50
Changes in other operating assets and liabilities:
Accounts receivable, net	78	(110)	(110)
Related party note receivable	7
Inventories	27	(180)	(83)
Other assets	55	(11)	24
Accounts payable	59	45	77
Accrued expenses and other liabilities	(380)	143	252
Net cash provided by operating activities	3,736	1,055	321
Cash flows from investing activities:
Capital expenditures	(303)	(338)	(305)
Turnaround expenditures	(57)	(83)	(5)
Acquisition of businesses, net of cash acquired	(20)		(20)
Proceeds from sale of investments		153	445
Proceeds from disposition of businesses and assets	33	4	414
Related party note receivable payments and distributions, net	30
Other, net	27	4	(1)
Net cash (used in) provided by investing activities	(290)	(260)	528
Cash flows from financing activities:
Investment segment contributions from non-controlling interests		9	79
Investment segment distributions to non-controlling interests	(2,199)	(23)	(5)
Partnership contributions	185	768	835
Partnership distributions	(307)	(226)	(134)
Purchase of additional interests in consolidated subsidiaries	158	(1)
Dividends and distributions to non-controlling interests in subsidiaries	(319)	(270)	(101)
Proceeds from Holding Company senior unsecured notes	699		1,214
Repayments of Holding Company senior unsecured notes	(1,159)	(500)	(1,205)
Proceeds from subsidiary borrowings	683	115	1,165
Repayments of subsidiary borrowings	(112)	(216)	(1,545)
Other, net	(14)		(10)
Net cash (used in) provided by financing activities	(2,385)	(344)	293
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents	(1)	(1)	3
Net increase in cash and cash equivalents and restricted cash and restricted cash equivalents	1,060	450	1,145
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period	4,886	4,436	3,291
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period	$ 5,946	$ 4,886	$ 4,436